Advertisement

Xilio Therapeutics, Inc. XLO

Set alert

Price alert · XLO

All alert types
8.03 USD +0.10 +1.26%

At close · Oct 30

8.03 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
8.00 × 1
Ask
8.14 × 4
7.05 Day range 8.09
7.14 52-week range 11.90
YTD
-10.38%
1 year
-28.69%
Open
7.05
Prev close
7.93
Mkt cap
52.84M
Vol
7.72K
Avg vol
12.41K
EPS
-0.60
P/E
0.00
Div yield
0.00%
More statistics
Low
7.05
High
8.09
Forward P/E
-1.91
Beta
-0.20
Short ratio
0.42
Inst. own
29.50%
Dividend
0.00
Ex-div date
Earnings
Aug 8, 2024
50-d avg
1.01
200-d avg
0.970715
1y target
4.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for XLO has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $18.69MGross Profit → Expenses: $18.69MExpenses → Selling, General & Admin: $7.62MExpenses → Research & Development: $14.56MExpenses → Other Expenses: $2.88MNet Loss → Expenses: $6.37MGross Profit$18.69MNet Loss$6.37MExpenses$25.07MSelling, General & Admin$7.62MResearch & Development$14.56MOther Expenses$2.88MRevenue$18.69M

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

XLO quarterly income statement
18.69M
18.69M
18.69M
22.18M
14.56M
7.62M
-3.49M
-6.37M
-6.37M
-6.37M
-6.37M
-0.33
-0.33
-0.33
-6.37M
-6.37M
19.40M
19.40M

Balance sheet

XLO quarterly balance sheet
137.86M
137.86M
6.00M
145.47M
6.97M
154.25M
1.43M
6.30M
34.20M
4.88M
81.99M
-434.69M
72.26M
72.26M
8.79M
6.30M
35.32M
47.79M
2.31M

Cash flow

XLO quarterly cash flow
331.00K
4.49M
-14.29M
-19.00K
4.49M
-19.00K
-18.76M
1.60M
Advertisement